CapsoVision (CV) Assets Average (2025)

CapsoVision's (CV) quarterly Assets Average came in at $21.9 million in Q4 2025, up 24.47% quarter-over-quarter from $17.6 million in Q3 2025.

CapsoVision (CV) Assets Average (2025) Analysis & Trends

CapsoVision has disclosed Assets Average across 1 years of filings, most recently posting $21.9 million for Q4 2025.

Assets Average for Q4 2025 came in at $21.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $21.9 million (changed N/A YoY), and the FY2025 annual result was $17.5 million, changed N/A from the prior year.
Assets Average came in at $21.9 million for Q4 2025 at CapsoVision, up from $17.6 million in the prior quarter.
In the past five years, Assets Average ranged from a high of $21.9 million in Q4 2025 to a low of $13.2 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	98.57 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	47.07 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	91.42 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	44.01 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	13.51 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	31.64 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	6.49 Bn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	37.02 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	10.66 Bn
10	CapsoVision	161.82 Mn	151.71 Mn	1.95 Mn	21.91 Mn

Download Data